ATE273696T1 - Dosierungsform von ibuprofen - Google Patents

Dosierungsform von ibuprofen

Info

Publication number
ATE273696T1
ATE273696T1 AT97903352T AT97903352T ATE273696T1 AT E273696 T1 ATE273696 T1 AT E273696T1 AT 97903352 T AT97903352 T AT 97903352T AT 97903352 T AT97903352 T AT 97903352T AT E273696 T1 ATE273696 T1 AT E273696T1
Authority
AT
Austria
Prior art keywords
dosage form
ibuprofen
fever
bicarbonate
pain
Prior art date
Application number
AT97903352T
Other languages
English (en)
Inventor
Ian Ashley Price
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Application granted granted Critical
Publication of ATE273696T1 publication Critical patent/ATE273696T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97903352T 1996-02-21 1997-02-19 Dosierungsform von ibuprofen ATE273696T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9603699.1A GB9603699D0 (en) 1996-02-21 1996-02-21 Therapeutic composition
PCT/EP1997/000841 WO1997030699A2 (en) 1996-02-21 1997-02-19 Dosage form of ibuprofen

Publications (1)

Publication Number Publication Date
ATE273696T1 true ATE273696T1 (de) 2004-09-15

Family

ID=10789176

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97903352T ATE273696T1 (de) 1996-02-21 1997-02-19 Dosierungsform von ibuprofen

Country Status (25)

Country Link
US (1) US20020034540A1 (de)
EP (1) EP0881899B1 (de)
JP (2) JP2000507922A (de)
KR (1) KR19990087084A (de)
CN (1) CN1215989A (de)
AT (1) ATE273696T1 (de)
AU (1) AU722991B2 (de)
BG (1) BG64165B1 (de)
CA (1) CA2246344C (de)
CZ (1) CZ298371B6 (de)
DE (1) DE69730314T2 (de)
DK (1) DK0881899T3 (de)
ES (1) ES2227670T3 (de)
GB (1) GB9603699D0 (de)
HU (1) HUP9901454A3 (de)
IL (1) IL125803A0 (de)
NO (1) NO983825L (de)
NZ (1) NZ331416A (de)
PL (1) PL187383B1 (de)
PT (1) PT881899E (de)
RU (1) RU2182000C2 (de)
SK (1) SK285032B6 (de)
UA (1) UA55407C2 (de)
WO (1) WO1997030699A2 (de)
ZA (1) ZA971446B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
NZ508292A (en) * 1999-11-24 2002-08-28 Mcneil Ppc Inc Treatment of migraine symptoms with ibuprofen and salts thereof
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
EP1379226A2 (de) * 2001-04-10 2004-01-14 Zagros Pharma Inc. Tiermodell zur auswertung von analgetika
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
CA2510320C (en) * 2002-12-20 2012-10-09 St. James Associates Llc/Faber Research Series Coated particles for sustained-release pharmaceutical administration
US20040176234A1 (en) * 2003-03-07 2004-09-09 Baker Hughes Incorporated Method for improving separation operation of centrifuges and associated improved separation designs
US20080020042A1 (en) * 2003-10-14 2008-01-24 Peter Gruber Dosage form of sodium ibuprofen
PE20050445A1 (es) * 2003-10-30 2005-06-18 Bayer Consumer Care Ag Forma de presentacion del naproxeno sodico
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
CN1976678B (zh) * 2004-06-29 2010-06-02 奈康明丹麦有限责任公司 水不溶性药快速释放药物组合物的制造方法及通过本方法得到的药物组合物
PT1804772E (pt) * 2004-08-12 2011-12-02 Reckitt Benckiser Healthcare Grânulos que compreendem um fármaco anti-inflamatório não esteróide e um álcool de açúcar feito por extrusão de fundido
CN101068532B (zh) * 2004-09-30 2012-03-14 斯科尔医药公司 布洛芬改进释放剂型
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
EP1817021A1 (de) * 2004-11-03 2007-08-15 Equitech Corporation Nsaid-zusammensetzungen mit klinischer qualität
ES2523988T3 (es) * 2005-02-09 2014-12-03 Boehringer Ingelheim International Gmbh Comprimidos recubiertos que contienen lisinato de ibuprofeno
US9205054B2 (en) 2005-03-22 2015-12-08 Losan Pharma Gmbh Solubilized ibuprofen
EP1800667A1 (de) 2005-12-23 2007-06-27 Losan Pharma GmbH Schnell lösliches Ibuprofen-Granulat
WO2007035448A2 (en) * 2005-09-19 2007-03-29 Albemarle Corporation Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
US9757455B2 (en) 2005-11-28 2017-09-12 Johnson & Johnson Consumer Inc. Oral therapeutic compound delivery system
KR101288924B1 (ko) * 2006-08-16 2013-07-24 에스에스 세야쿠 가부시키 가이샤 경구투여용 제제
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20070521L (fi) * 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
US7749537B2 (en) 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
CA2674776A1 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
EP2291233B1 (de) * 2008-05-09 2019-09-04 Atacama Labs Oy Verfahren für trockene granulation
BRPI0916344A2 (pt) * 2008-07-21 2020-07-21 Albemarle Corporation grânulos com alto teor de ibuprofeno de sódio, preparação e utilização para preparação de formas de dosagem sólidas não efervescentes
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US20110144207A1 (en) * 2008-08-14 2011-06-16 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
MX374707B (es) * 2009-06-22 2025-03-06 Pf Consumer Healthcare 1 Llc Comprimidos de ibuprofeno de sodio y procedimientos de fabricacion de composiciones farmaceuticas que incluyen ibuprofeno de sodio.
JP5974469B2 (ja) * 2010-12-24 2016-08-23 ライオン株式会社 錠剤の製造方法
CN103102259B (zh) * 2011-12-23 2014-02-26 海南正瑞医药科技开发有限公司 一种布洛芬水合物晶体、及含该水合物晶体的药物组合物及其制备方法
WO2015016256A1 (ja) * 2013-07-30 2015-02-05 ライオン株式会社 錠剤
EP2845850A1 (de) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidinderivate als Oxytocin/Vasopressin-V1a-Rezeptorantagonisten
EP2886107A1 (de) * 2013-12-17 2015-06-24 ObsEva S.A. Orale Formulierungen von Pyrrolydinderivaten
AU2015283133B2 (en) 2014-07-02 2019-05-16 ObsEva SA Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime useful in methods of treating conditions related to the OT-R activity
EP2965746B1 (de) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. Orale pharmazeutische Zusammensetzung mit Ibuprofen, Ibuprofennatriumdihydrat, Pseudoephedrinhydrochlorid und Chlorpheniraminmaleat
WO2017060920A1 (en) * 2015-10-05 2017-04-13 Strides Shasun Limited Pharmaceutical compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
US4684666A (en) * 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
JPH02500189A (ja) * 1986-10-22 1990-01-25 ジ・アップジョン・カンパニー イブプロフェンまたはフルルビプロフェンを用いる歯肉炎の治療
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
ES2148175T3 (es) * 1991-05-13 2000-10-16 Boots Co Plc Composicion farmaceutica que contiene una sal de ibuprofeno.
DE4216756C2 (de) * 1992-05-21 1994-08-25 Pharmatrans Sanaq Ag 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung
ATE180668T1 (de) * 1992-12-01 1999-06-15 Spirig Ag S(+)-ibuprofen enthaltende arzneimittel

Also Published As

Publication number Publication date
JP2000507922A (ja) 2000-06-27
KR19990087084A (ko) 1999-12-15
BG64165B1 (bg) 2004-03-31
HUP9901454A3 (en) 2001-04-28
WO1997030699A3 (en) 1997-10-09
NZ331416A (en) 2000-02-28
CZ261798A3 (cs) 1998-11-11
CN1215989A (zh) 1999-05-05
NO983825L (no) 1998-10-20
SK285032B6 (sk) 2006-05-04
RU2182000C2 (ru) 2002-05-10
ZA971446B (en) 1997-11-25
PT881899E (pt) 2004-12-31
NO983825D0 (no) 1998-08-20
EP0881899B1 (de) 2004-08-18
CZ298371B6 (cs) 2007-09-12
GB9603699D0 (en) 1996-04-17
EP0881899A2 (de) 1998-12-09
AU1793797A (en) 1997-09-10
UA55407C2 (uk) 2003-04-15
CA2246344A1 (en) 1997-08-28
DK0881899T3 (da) 2004-12-20
DE69730314D1 (de) 2004-09-23
PL328465A1 (en) 1999-02-01
IL125803A0 (en) 1999-04-11
DE69730314T2 (de) 2005-08-18
ES2227670T3 (es) 2005-04-01
BG102744A (bg) 1999-05-31
WO1997030699A2 (en) 1997-08-28
AU722991B2 (en) 2000-08-17
HUP9901454A2 (hu) 1999-08-30
PL187383B1 (pl) 2004-06-30
SK114298A3 (en) 1999-01-11
JP2009073847A (ja) 2009-04-09
US20020034540A1 (en) 2002-03-21
CA2246344C (en) 2009-01-20

Similar Documents

Publication Publication Date Title
DE69730314D1 (de) Dosierungsform von ibuprofen
ZA899372B (en) Hemostatic collagen paste composition
US5782971B1 (en) Calcium phosphate cements comprising amorophous calcium phosphate
IL116385A0 (en) Sulphonamides their manufacture and pharmaceutical compositions containing them
ES2046083A1 (es) Procedimiento para preparar composiciones de liberacion prolongada.
ATE182078T1 (de) Laxiermittel das ballastfasern und dioctyl- sulfosuccinat enthält
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
ES2188774T3 (es) Composiciones cosmeticas en polvo que tienen un poder cubriente mejorado.
ZA948669B (en) New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions
MY109990A (en) Microfluidised particles of atovaquone and pharmaceutical preparation thereof
EA200000506A1 (ru) Состав для снижения веса
ES8303090A1 (es) Procedimiento para la obtencion de comprimidos medicionales de rapida disgregacion.
DK1167354T3 (da) Racemisk huperzin A
AU4627096A (en) Pharmaceutical compositions in the form of slow release tablets based on high molecular weight polysaccharide granules
EP0237241A3 (de) Komprimierte Tabletten mit Kalziumzusatzstoff
GB0300654D0 (en) Detergent compositions
GR3036470T3 (en) Process for preparing a clodronate preparation
ES2085199A1 (es) Un procedimiento para la preparacion de una formulacion depot.
ES2192064T3 (es) Composicion gelatinosa de pescado para usar como ingrediente en comprimidos.
RU94017651A (ru) Строительный раствор для консолидации и/или уплотнения грунтов
MD566C2 (ro) Procedeu de preparare a materialului plastic sclerosuspendator din ţesutul osos
KR880012206A (ko) 구강질환 치료 조성물
ES2032237A1 (es) Procedimiento para preparar carne simulada de marisco.
UA26922C2 (uk) Похідhі сульфамідосульфоhілсечовиhи, що мають гербіцидhу активhість,та гербіцидhа композиція hа їх осhові
RU98118896A (ru) Лечебно-профилактическое средство

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0881899

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee